These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Introduction to the problems of clinical pharmacological research]. Rahlfs VW Int J Clin Pharmacol; 1972 Nov; 6(4):385-90. PubMed ID: 4565837 [No Abstract] [Full Text] [Related]
3. How to read clinical journals: V: To distinguish useful from useless or even harmful therapy. Can Med Assoc J; 1981 May; 124(9):1156-62. PubMed ID: 7016293 [No Abstract] [Full Text] [Related]
4. Analysis of Poisson data in crossover experimental designs. Layard MW; Arvesen JN Biometrics; 1978 Sep; 34(3):421-8. PubMed ID: 363188 [No Abstract] [Full Text] [Related]
5. Conditional power calculations for clinical trials with historical controls. Korn EL; Freidlin B Stat Med; 2006 Sep; 25(17):2922-31. PubMed ID: 16479548 [TBL] [Abstract][Full Text] [Related]
6. Paired versus two-sample design for a clinical trial of treatments with dichotomous outcome: power considerations. Wacholder S; Weinberg CR Biometrics; 1982 Sep; 38(3):801-12. PubMed ID: 7171700 [TBL] [Abstract][Full Text] [Related]
8. Comments on 'Current issues in non-inferiority trials' by Thomas R. Fleming, Statistics in Medicine, DOI: 10.1002/sim.2855. Koch GG Stat Med; 2008 Feb; 27(3):333-42. PubMed ID: 17530625 [No Abstract] [Full Text] [Related]
9. Statistical significance, power and sample size--Part 2. Christley RM J Small Anim Pract; 2008 Jul; 49(7):321-2. PubMed ID: 18638056 [No Abstract] [Full Text] [Related]
10. Type II error in clinical trials. Gordon RS Gastroenterology; 1980 Jul; 79(1):180. PubMed ID: 7380213 [No Abstract] [Full Text] [Related]
11. Effects of reporting lags on interim inferences from clinical trials. Gelman R Experientia Suppl; 1982; 41():175-86. PubMed ID: 6958509 [No Abstract] [Full Text] [Related]
12. Clinical trials. Smith AJ Med J Aust; 1984 Jun; 140(12):720-3. PubMed ID: 6727737 [No Abstract] [Full Text] [Related]
14. [Decision making in clinical research: a statistical approach]. Lacaine F; Huguier M Gastroenterol Clin Biol; 1980 Nov; 4(11):754-7. PubMed ID: 7461386 [No Abstract] [Full Text] [Related]
15. [Principles of selection of control groups in clinical and prophylactic trials]. Magnus K Nord Med; 1969 Nov; 82(47):1465-70. PubMed ID: 4903456 [No Abstract] [Full Text] [Related]
16. Statistical issues in the design and evaluation of clinical trials in Kawasaki disease. Gould AL Prog Clin Biol Res; 1987; 250():459-70. PubMed ID: 3423055 [No Abstract] [Full Text] [Related]
18. [How many persons do we need for clinical trials? Analysis of the 2 x 2 table]. Vollset SE Tidsskr Nor Laegeforen; 1983 Nov; 103(33):2219-21. PubMed ID: 6658747 [No Abstract] [Full Text] [Related]
19. Are there two studies that clearly reveal superiority of drug over placebo? Overall JE; Rhoades HM Psychopharmacol Bull; 1984; 20(1):64-7. PubMed ID: 6718653 [No Abstract] [Full Text] [Related]
20. Statistical methods in clinical trials. Gebski VJ; Keech AC Med J Aust; 2003 Feb; 178(4):182-4. PubMed ID: 12580749 [No Abstract] [Full Text] [Related] [Next] [New Search]